Zobrazeno 1 - 10
of 135
pro vyhledávání: '"Shravanthi R. Gandra"'
Autor:
Peter P. Toth, Gillian Worthy, Shravanthi R. Gandra, Naveed Sattar, Sarah Bray, Lung‐I. Cheng, Ian Bridges, Gavin M. Worth, Ricardo Dent, Carol A. Forbes, Sohan Deshpande, Janine Ross, Jos Kleijnen, Erik S. G. Stroes
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 10 (2017)
BackgroundThe proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors evolocumab and alirocumab substantially reduce low‐density lipoprotein cholesterol (LDL‐C) when added to statin therapy in patients who need additional LDL‐C reducti
Externí odkaz:
https://doaj.org/article/7f9fd7632f2a455c94947fb72b3ea045
Autor:
Anthony Wang, Akshara Richhariya, Shravanthi R. Gandra, Brian Calimlim, Lisa Kim, Ruben G. W. Quek, Robert J. Nordyke, Peter P. Toth
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 7 (2016)
BackgroundApheresis is an important treatment for reducing low‐density lipoprotein cholesterol (LDL‐C) in patients with familial hypercholesterolemia (FH). We systematically reviewed the current literature surrounding LDL‐C apheresis for FH. Me
Externí odkaz:
https://doaj.org/article/b6f4e2bb66ee4faba14db47b4c70165c
Autor:
Kevin H. Lin, Lynn Huynh, Xiaoqin Yang, Neema Lema, Lisa Matay, Sobana Balasubramanian, Daria Liborski, Mikaela M. McDonough, Jillian Foreman, Mohammed Z.H. Farooqui, Enrico De Nigris, Shravanthi R. Gandra, Eric Sarpong, Mei Sheng Duh, Jennifer R. Brown, Matthew S. Davids
Publikováno v:
Blood. 140:4150-4152
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d69ae57b8a7007ca112a2154adf34c20
https://doi.org/10.1182/blood-2022-160389
https://doi.org/10.1182/blood-2022-160389
Publikováno v:
Journal of Bone and Mineral Research. 36:2309-2316
The 2020 American Association of Clinical Endocrinologists guidelines for assessing osteoporosis among postmenopausal women stratified postmenopausal women with osteoporosis to "high" and "very-high" fracture risk categories and recommended anabolic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::615d43c438614d10e5bdb5e015ea292e
https://doi.org/10.1002/jbmr.4439
https://doi.org/10.1002/jbmr.4439
Publikováno v:
Osteoporosis International. 33:413-423
We comprehensively described elderly Medicare women with an outpatient visit in 2011 and fracture within 2 years before. These women were at very high risk for subsequent fracture and high healthcare utilization and cost, especially those with verteb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6ba1574caa192beba413faca3737cce
https://doi.org/10.1007/s00198-021-06084-1
https://doi.org/10.1007/s00198-021-06084-1
Publikováno v:
Osteoporosis International
Summary Osteoporosis, a chronic disease, requires long-term therapy. In Medicare-insured women, denosumab persistence was higher than oral bisphosphonate persistence over up to 3 years of follow-up. Longer-term persistence was higher among women who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7b82b67aba2154f34405330d9c4d629
https://doi.org/10.1007/s00198-021-05951-1
https://doi.org/10.1007/s00198-021-05951-1
Autor:
B. Stollenwerk, K. Adachi, Shravanthi R. Gandra, Michael R. McClung, Kiyoshi Tanaka, H. Hagino, S. Silverman, M. Charokopou, B. Johnson
Publikováno v:
Osteoporosis International. 32:2011-2021
Summary This study assessed the cost effectiveness of romosozumab versus teriparatide, both sequenced to alendronate, for the treatment of severe postmenopausal osteoporosis in Japan, using bone mineral density (BMD) efficacy data. Results show that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65c7096ae651f3ad13239f8cea994fb1
https://doi.org/10.1007/s00198-021-05927-1
https://doi.org/10.1007/s00198-021-05927-1
Autor:
Machaon Bonafede, Shravanthi R. Gandra, Stuart L. Silverman, Michele McDermott, Kathleen M. Fox, Oth Tran, Xiaoqing Xu
Publikováno v:
Osteoporosis International
Summary The study examined long-term direct and indirect economic burden of osteoporotic fractures among postmenopausal women. Healthcare costs among fracture patients were substantial in first year after fracture and remained higher than fracture-fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76f40509516022cd2240b4ec2d6f0460
https://doi.org/10.1007/s00198-020-05769-3
https://doi.org/10.1007/s00198-020-05769-3
Autor:
Shravanthi R. Gandra, Kathleen M. Fox, Rajeshwari S. Punekar, Akshara Richhariya, Peter P. Toth, Mark J. Cziraky, Carly J. Paoli
Background: Numerous studies demonstrate that, even with use of statins, many patients are unable to meet their LDL-C goals. This study examined modifications to statin and/or ezetimibe therapy among patients with hyperlipidemia and prior history of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec61273dd7fd24f09a8cdad29af2435b
